Lipid-lowering efficacy and safety after switching to atazanavir-ritonavir-based highly active antiretroviral therapy in patients with human immunodeficiency virus (Q45396970)

From Wikidata
Jump to navigation Jump to search
scientific article published in March 2008
edit
Language Label Description Also known as
English
Lipid-lowering efficacy and safety after switching to atazanavir-ritonavir-based highly active antiretroviral therapy in patients with human immunodeficiency virus
scientific article published in March 2008

    Statements

    Lipid-lowering efficacy and safety after switching to atazanavir-ritonavir-based highly active antiretroviral therapy in patients with human immunodeficiency virus (English)
    Sean T Nguyen
    Susan A Eaton
    Amy M Bain
    Anita P Rahman
    Kenna D Payne
    Roger Bedimo
    Jon D Herrington
    Darego O Maclayton
    Maria C Rodriguez-Barradas
    Anthony J Busti
    1 March 2008
    323-330

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit